Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

Home › Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

23.09	Mortgages at six times' income for first-time buyers
23.09	Tropical Storm John Graphics
23.09	Tropical Storm John Public Advisory Number 3A
23.09	Summary for Tropical Storm John (EP5/EP102024)
23.09	Eastern North Pacific Tropical Weather Outlook
23.09	Atlantic Tropical Weather Outlook
23.09	Are your barns winter ready?
23.09	Emerging Pork Leaders Carolina now accepting applications
More »

je.st